SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma-Reference-Cited by-同舟云学术

SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma

Published:2017-08-14 Issue:40 Volume:8 Page:68381-68392
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kim Yun Hak¹,Jeong Dae Cheon²,Pak Kyoungjune³,Han Myoung-Eun¹,Kim Ji-Young¹,Liangwen Liu¹,Kim Hyun Jin⁴,Kim Tae Woo⁵,Kim Tae Hwa⁶,Hyun Dong Woo⁷,Oh Sae-Ock¹

Affiliation:

1. Department of Anatomy, School of medicine, Pusan National University, Yangsan, Republic of Korea

2. Department of Statistics, Korea University, Seoul 02841, Republic of Korea

3. Department of Nuclear Medicine, Pusan National University Hospital, Busan, Republic of Korea

4. Eco-friendly new materials research center, Korea Research Institute of Chemical Technology (KRICT), Daejeon, Republic of Korea

5. Department of Orthopaedic Surgery, Pusan National University Hospital, Yangsan, Republic of Korea

6. Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea

7. Department of General Surgery, Pusan National University Hospital, Busan, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy;ACS Pharmacology & Translational Science;2024-09-05

2. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy;Cancer Drug Resistance;2024-07-18

3. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets;Heliyon;2024-04

4. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy;2024-03-28

5. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers;Diseases;2024-03-21